Brainsway Set to Begin Clinical Trial for Smoking Cessation in Chronic Obstructive Pulmonary Disease Patients

16 September, 2009

Further to that stated in Brainsway’s report dated June 29th 2009, regarding receipt of the Ministry of Health's approval for the performance of a clinical trial at the Be'er Ya'akov Mental Health Center designed to assess the efficacy of the Company's Deep TMS device in inducing smoking cessation in chronic obstructive pulmonary disease patients, Brainsway is pleased to announce that it has received approval for the trial from the Director of the Be’er Ya’akov Mental Health Center, as required by the Procedure for Clinical Investigations in Human Subjects (2005).

In addition, the Company has signed a clinical trial agreement with the mental health center, establishing the terms of the collaboration between the parties.
The trial is set to begin in the near future.